A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes

NCT00630851 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

249

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Donepezil (Aricept)
DRUG: Placebo

Sponsor

Pfizer